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ABSTRACT
Hemodialysis (HD) catheter-related infection (CRI) and
septicemia contribute to adverse outcomes. The impact
of seasonality and prophylactic dialysis practices during
high-risk periods remain unexplored. This multicenter
study analyzed DOPPS data from 12,122 HD patients
(from 442 facilities) to determine the association between
seasonally related climatic variables and CRI and septi-
cemia. Climatic variables were determined by linkage to
National Climatic Data Center of National Oceanic and
Atmospheric Administration data. Catheter care proto-
cols were examined to determine if they could mitigate
infection risk during high-risk seasons. Survival models
were used to estimate the adjusted hazard ratio (AHR)
of septicemia by season and by facility catheter dressing
protocol. The overall catheter-related septicemia rate was
0.47 per 1000 catheter days. It varied by season, with an
AHR for summer of 1.46 (95% CI: 1.19–1.80) compared
with winter. Septicemia was associated with temperature
(AHR = 1.07; 95% CI: 1.02–1.13; p < 0.001). Dressing
protocols using chlorhexidine (AHR of septice-
mia = 0.55; 95% CI: 0.39–0.78) were associated with
fewest episodes of CRI or septicemia. Higher catheter-
related septicemia in summer may be due to seasonal
conditions (e.g., heat, perspiration) that facilitate bacte-
rial growth and compromise protective measures. Extra
vigilance and use of chlorhexidine-based dressing proto-
cols may provide prophylaxis against CRI and
septicemia.
Hemodialysis (HD) catheter placement rates and
duration of use have increased over the last two dec-
ades (1,2). Approximately 80% of North American
patients initiate HD with a catheter, with recent data
indicating catheter use rates of approximately 50%,
4 months after dialysis initiation (1,2). A potentially
devastating complication of HD catheter use is infec-
tion. In HD patients, infection is the most common
cause of morbidity and the second most common
cause of death (1,3). The risk of a sepsis-attributable
death is 100 times that of the general population (4).
HD catheters pose the highest risk of bacteremia, sep-
sis, and death compared with other vascular access
types (5–10). It has been estimated that, annually,
approximately 30% of patients using a central venous
catheter experience a bacteremic or septic episode (9).
Despite proven prophylactic strategies (10) and
widely distributed guidelines on the prevention of
access-related infections (11–13), infection rates
remain high and a significant concern. Identifying
circumstances where patients are at high risk of
catheter-related infection and their complications
can help target prophylactic efforts. For example,
infection-related hospitalization rates are particu-
larly high in the first 2 months after dialysis initia-
tion (14). Another predictable occurrence is the
change in environmental heat and humidity associ-
ated with climate and the seasons. Climate and
seasonal variability has long been associated with
disease (15). Higher heat and humidity may be more
conducive to bacterial growth and the risk of cathe-
ter-related septicemia and their complications. The
impact of climate, seasonality, environmental tem-
perature, and humidity on vascular access-related
septicemia is unknown.
The Dialysis Outcomes and Practice Patterns
Study (DOPPS) is a prospective, longitudinal,
observational study of HD patients and facilities in
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12 countries. Furthermore, the DOPPS has a focus
to determine readily modifiable means to improve
patient outcomes. The global nature of the DOPPS
is ideally poised to determine whether an associa-
tion exists between catheter-related septicemia and
seasonality and to determine modifiable practice
patterns that may assist in reducing catheter-related
septicemia in high-risk situations.
Subjects and Methods
Daily climate data from 1996 to 2002 were down-
loaded from the National Climatic Data Center
(NCDC) of the National Oceanic and Atmospheric
Administration (NOAA) website. At the time of
dataset creation, this was the most current and avail-
able data; NCDC data were then linked to each
DOPPS facility by mapping to the nearest weather
station (16). The climate data set has daily climate
data that include the mean, minimum, and maximum
temperatures, absolute and relative humidity, dew
point, precipitation, and station atmospheric pres-
sure. Data from 1996 to 2002 were used to obtain
average climate information for each day of the year
for each DOPPS facility location. The data set also
has data on the elevation from sea level, longitude,
and latitude of each of the DOPPS facilities.
Data were abstracted from DOPPS phases I, II,
and III (1996–2009). DOPPS is a prospective obser-
vational study in 12 countries (Australia, New Zea-
land, Belgium, Canada, France, Germany, Italy,
Japan, Spain, Sweden, United Kingdom, and the
United States), which is based on nationally repre-
sentative samples of randomly selected dialysis facil-
ities and patients. The DOPPS sampling plan and
study design have been described previously (17).
To assess the association between catheter-related
septicemia and seasonality and to determine modifi-
able practice patterns that may assist in reducing
catheter-related septicemia, the current analyses
were limited to tunneled catheter-related vascular
access data of 12,122 HD patients from DOPPS I,
II, and III. These patients had a total of 973 infec-
tions, 1682 septicemia hospitalizations, and 1862
vascular access-related infections other than septice-
mia. A final data set was created with one observa-
tion per person per week of tunneled catheter use
(from tunneled catheter start date until catheter last
use date or infection date in case of an infection
event) with the average climate information for the
facility location based on the day and month of the
year. Seasons were defined using approximate dates
for the solstices and equinoxes: Winter (December
22), Spring (March 22), Summer (June 22), and Fall
(September 23). The differences in seasons were
accounted for in Australia and New Zealand (i.e.,
data from winter in Australia were made to coincide
with data from winter in North America, even
though these seasons are 6 months apart). To look
at vascular access-related practices and their associ-
ation with catheter-related septicemia, we evaluated
the dressing protocol/cleansing agent used by dialy-
sis facilities for vascular access care. The five cleans-
ing agents used by facilities included alcohol,
betadyne, chlorhexidine, soap and water, and a
combination of agents.
Catheter-related septicemia was defined as septi-
cemia during or within 15 days after HD catheter
use. Septicemia was defined by a hospitalization
where at least one hospitalization diagnosis was
“septicemia”. As a sensitivity analysis, hospitaliza-
tions involving both septicemia and a list of other
diagnoses indicating that the septicemia might be
due to something other than the catheter (e.g.,
pneumonia, wound, abcess, cellulitis, etc.) were
excluded. Catheter time at-risk and catheter-related
septicemia were assigned to one of four seasons in
each country.
Statistical Methods
Rates of catheter-related infection and septicemia
per 1000 patient-days of follow-up with a catheter
were plotted by calendar month. Both unadjusted
and adjusted relative rates of catheter-related infec-
tion and septicemia by season were determined by
using time-dependent Cox proportional hazards
regression models. These models, updated weekly
for climate and season data, were also used to
determine the associations of facility daily climate
data or facility vascular access cleansing solutions
with catheter-related infection or septicemia. All
models were adjusted for age, race, sex, 13 summary
comorbidities (coronary artery disease, other cardiac
disease, cerebrovascular disease, congestive heart
failure, diabetes, gastrointestinal bleeding, hyperten-
sion, peripheral vascular disease, lung disease,
neurologic disorder, cancer [excluding skin], psychi-
atric disease, recurrent cellulitis, and HIV infection),
phase, and country. Robust variance estimates
(sandwich estimator) were used to account for
patient-level clustering of infection rates. Only the
first infection or septicemia event per catheter was
analyzed. All statistical analyses were performed
using SAS software, version 9.2 (SAS Institute,
Cary, NC).
Results
We analyzed 12,122 HD patients in 12 countries
from DOPPS I, II, and III (1996–2009) and
2,070,254 catheter days at-risk. Overall, the cathe-
ter-related septicemia rate was 0.47/1000 catheter
days. The catheter-related septicemia rate was 0.52/
1000 catheter days in North America, 0.35/1000
catheter days in Japan, and 0.41 per 1000 catheter
days in Europe/Australia/New Zealand. The occur-
rence of catheter-related septicemia varied by month
(Fig. 1) with an adjusted hazard ratio (AHR) for
“summer” of 1.46 (95% CI: 1.19–1.80) compared
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with “winter” (Table 1). As a sensitivity analysis,
these results were redone excluding hospitalizations
where the septicemia might have been due to
another cause (e.g., pneumonia). The seasonal septi-
cemia rates were 0.02–0.03/1000 catheter days lower
after excluding these admissions, but showed the
same overall pattern. As a result of these rate
changes, the AHR values after excluding these
admissions increased by AHR=0–0.03; for exam-
ple, the AHR for “summer” compared with “win-
ter” changed from 1.46 to 1.48 (95% CI: 1.19–1.83).
Climate-related variables had an association with
catheter-related infections primarily through their
association with temperature. Adjusting each vari-
able for demographics and comorbid conditions, the
following list of climate variables were significantly
associated with catheter-related infections: absolute
humidity (AHR 1.17 per 10 g/m3 [95% CI: 1.09–
1.27; p < 0.001]), latitude (AHR 0.86 per 10° [95%
CI: 0.79–0.95; p < 0.001]), mean temperature (AHR
1.08 per 10° [95% CI: 1.04–1.12; p < 0.001]), mini-
mum temperature (AHR 1.08 per 10° [95% CI:
1.05–1.12; p < 0.001]), maximum temperature (AHR
1.07 per 10° [95% CI: 1.04–1.12; p < 0.001]), and
mean dew point (AHR 1.07 per 10°F [95% CI:
1.04–1.11; p < 0.001]). When minimum temperature
was included—along with the demographics and co-
morbid factors—as a covariate in the models using
the various climate factors (Table 2), none of the
other factors were statistically significant, indicating
that humidity and dew point were only associated
with infections through their correlation with
temperature. These results were similar to those
obtained when septicemia alone, instead of any
infection, was used as the outcome. There appeared
to be a statistically significant relationship between
latitude and septicemia (p = 0.03), but not infection
(p = 0.39).
Catheter-related septicemia was lower with use of
chlorhexidine (AHR = 0.55; 95% CI: 0.39–0.78) or
iodine-based antiseptics, e.g., betadyne (AHR =
0.57; 95% CI: 0.42, 0.78), versus alcohol solutions,
with similar AHR for combined cleansing agents
(AHR = 0.60; 95% CI: 0.36, 0.98). Soap and water
was only used in six of the facilities, which may be
why their results (AHR = 1.37; 95% CI: 0.51–3.7)
were not significantly worse than alcohol. Betadyne
and alcohol were used in 68 of the facilities; this
combination trended toward lower catheter-related
septicemia when compared with alcohol alone
(AHR = 0.72, 95% CI: 0.51–1.02). The combination
was also associated with significantly higher cathe-
ter-related septicemia rates than betadyne alone
(AHR = 1.26, 95% CI: 1.00–1.58). There was no
interaction with any of the cleansing agents and the
seasons.
Discussion
This study found distinct seasonal variation in
the incidence of catheter-related septicemia, with an
increased risk of 46% during the summer months.
This association persisted around the globe, even
after accounting for differences in seasons based on
geographic region (e.g., where July and August is
summer in the Northern hemisphere, but winter in
the Southern one). Consistent with the seasonal
findings was the positive association between
temperature and catheter-related infections. Fur-
thermore, the study identified certain facility prac-
tice patterns that reduced the risk of infection, such
as catheter care with appropriate antisepsis.
While the general relationship between season
and disease has been long recognized (15), seasonal-
ity has been only provisionally reported in relation
to access-related infection in the HD population
(18,19). However, in the peritoneal dialysis litera-
ture, peritonitis rates have been found to vary with
seasons. Both Kim et al. and Szeto et al. described
increased incidence during seasons of high tempera-
ture and humidity (20,21). Such findings are consis-
tent with our finding of higher access-related
infections and septicemia rates during the summer.
Furthermore, the organisms that demonstrate
seasonality for peritonitis are also those that cause
catheter-related septicemia. In the peritoneal dialysis
TABLE 1. Rate of first recorded catheter-related infection and septicemia (per 1000 catheter days) by season
Season Fall Winter Spring Summer Total
Infection rate 0.82 0.83 0.90 1.07 0.91
Septicemia rate 0.32 0.31 0.34 0.44 0.35
Infection AHR 1.00 (0.87–1.14) 1 (ref) 1.10 (0.97–1.26) 1.32 (1.16–1.50)
Septicemia AHR 1.08 (0.86–1.34) 1 (ref) 1.13 (0.91–1.41) 1.46 (1.19–1.80)
AHR = Adjusted hazard ratio for each season calculated using Cox time-dependent models on infection and septicemia, controlling
for DOPPS phase, country, age, sex, race (Black versus non-Black), and 13 comorbid conditions.
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Fig. 1. Catheter-related infection and septicemia by month.
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literature, S. epidermidis, gram-negative organisms,
and culture-negative infections were most frequent
during hot months of the year, while S. aureus was
uniformly distributed throughout the year (22).
Staphylococcus aureus is the culprit organism identi-
fied in approximately one-third (27–39%) of
bacteremias in dialysis patients (23,24). Our study
was unable to examine the type of organism causing
episodes of septicemia. However, DOPPS data are
derived from a random sampling of dialysis patients
and, as such, are representative of the general facil-
ity dialysis population from a given region, and
probably, the organisms contributing to septicemia.
It is likely that a hot climate associates the sum-
mer months with a high incidence of catheter-
related infections in both peritoneal and HD
patients (21,25). Sweat and dirt are more likely to
accumulate around the catheter exit site during the
summer months (20,21,26). Protective barriers, such
as bandages, gauzes and/or antibiotic ointments, are
less likely to remain intact on dialysis patients as
they sweat. Further potential infection risks occur
when patients attempt to replace lost dressings
under suboptimal conditions. Heat and humidity
may enhance growth of bacteria and fomites on
catheter tubing, hubs, caps, and other reservoirs,
and increase the risk of exit site, peritoneal, or HD
catheter-related infections. This clinical postulate is
consistent with the pathophysiology of catheter-
related infections and sepsis, with biofilm as a
central requirement (10,27).
A biofilm is an organized assembly of surface-
associated microbial cells (micro-colonies) enclosed
in a protective extracellular polysaccharide matrix.
They adhere to and develop on living and nonliving
materials in contact with liquid or damp environ-
ments. They are found in natural ecologic, man-
made industrial and human environments. Biofilms
are involved in over 65% of infections in the body
(28) and have been long established to play a patho-
logic role in device-associated infections (29). Heat
and atmospheric conditions are known to affect
biofilm formation (30). Increasing temperature can
accelerate colonization and increase the quantity
and thickness of the biofilm biomass (31–35). Fur-
thermore, the colony count of skin bacteria (e.g.,
S. epidermidis, S. aureus) at the internal jugular and
subclavian exit site has been documented to be
approximately 1000–10,000 cfu/cm2 (36), with 80%
residing in the top five layers of the stratum corne-
um (37). The deeper hair follicles and sebaceous
glands may be stimulated in heated conditions and
harbor the remaining 20% of organisms within bio-
films that provide extra protection against antiseptic
agents (38–40). HD patients using a catheter during
the summer months with high temperatures and
humidity are therefore in the ideal setting for bio-
film growth and dispersion, culminating ultimately
in a higher rate of infection and septicemia.
While the climate and seasons cannot be altered,
the associated environmental factors, particularly in
relation to the pathophysiology of infection and
septicemia in HD patients using a catheter, should
be considered in prophylactic strategies. Patients at
high risk, such as those with a prior bacteremic epi-
sodes (7,41) recent hospitalizations (42), immuno-
compromised state (41,42), and poor hygiene (7,42),
should have their catheter care and evaluation per-
formed by qualified dialysis staff. Excellent catheter
care and appropriate antisepsis can reduce microor-
ganism entry, adherence to the catheter, and bio-
film development via extraluminal routes available
by intercutaneous breaks at the catheter exit site.
This is supported by the findings in our study,
where the use of chlorhexidine and iodine-based
cleansing agents, compared with alcohol-based
cleansing solutions, protected against catheter-
related infections. Our findings are consistent with
randomized studies and meta-analysis of prophylac-
tic cleansing agents used in high-risk settings,
including in the HD population (43–45). Of note,
our study extends the findings of the early land-
mark randomized controlled trial of povidone–
iodine that demonstrated a reduction in exit-site
infections, catheter tip colonization and bacteremias
in a single center using temporary catheters
(45).Common sense prevention such as hand wash-
ing prior to replacing dressings easily dislodged by
excessive sweat, meticulous catheter care, use of air
conditioning and dehumidifiers, and replacing damp
TABLE 2. Relationship between climate measures and CVC-related infections or septicemia, adjusting for minimum temperature
Infection Septicemia
AHRa 95% CI p-value AHRa 95% CI p-value
Absolute humidity (per 10 g/m3) 0.95 (0.77, 1.18) 0.66 0.86 (0.61, 1.2) 0.37
Relative humidity (per 10%) 0.98 (0.93, 1.02) 0.33 0.98 (0.9, 1.06) 0.63
Latitude (per 10°) 0.95 (0.86, 1.06) 0.39 1.20 (1.02, 1.41) 0.03
Mean temp (per 10°F) 1.00 (0.84, 1.17) 0.96 1.08 (0.83, 1.41) 0.56
Max. temp (per 10°F) 0.98 (0.89, 1.07) 0.62 1.03 (0.9, 1.19) 0.66
Min. temp (per 10°F) 1.08 (1.05, 1.12) <.001 1.07 (1.02, 1.13) 0.01
Difference in temp (per 10°F) 0.98 (0.89, 1.07) 0.62 1.03 (0.9, 1.19) 0.66
Elevation (per 100 m) 1.00 (0.98, 1.02) 1.00 1.00 (0.97, 1.03) 0.95
Mean dew point (per 10°F) 0.92 (0.81, 1.05) 0.23 0.95 (0.77, 1.18) 0.65
Total precipitation (per inch) 1.17 (0.86, 1.6) 0.32 1.52 (0.96, 2.4) 0.07
aCox time-dependent models on infection and septicemia control for DOPPS phase, country, age, male, race (Black versus non-Black),
minimum temperature, and 13 comorbid conditions.
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clothing or carefully toweling dry sweaty necks and
chests can be easily taught and implemented to
patients and dialysis healthcare providers. Proven
strategies for access-related infection prophylaxis
have been well-documented (10,27).
Limitations
This was an observational study that linked
DOPPS dialysis units to the closest weather station.
The precise temperature and humidity on the day of
diagnosed septicemia may not have been possible.
Only one observation per person per week of cathe-
ter use was analyzed, and the climate data were
averaged, based on the location and time of the
year. Therefore, the relationships between infection
rates and climate variables are likely to have been
attenuated by statistical noise, which would tend to
increase the chances of obtaining a nonsignificant
result. There may have been changes in practice pat-
tern over time that is not captured by DOPPS data,
such as use of hand sanitizers or treatment for nasal
S. aureus carriers. However, such changes would
not specifically and consistently affect catheter-
related infections only in a particular season over
several years. However, the observational nature of
this study limits our ability to comprehensively
adjust for important factors, such as personal
hygiene or socioeconomic status, which may impact
infection rates. In addition, analyses of recurrent
infections within the same person were limited as
these infections are plausibly not independent of
each other, even though only the first infection
attributed to a single catheter was included. Recur-
rent or new infections in the same catheter would
have been excluded. Thus, given that having had a
catheter-related infection increases the risk of a sub-
sequent infection, the overall rate of catheter-related
infection or septicemia attributed to a catheter may
be underestimated. Analyses of time-to-first infec-
tion rates within a season are also limited, in that
multiple infections for a particular patient within a
season would not have been counted. Thus, the true
rate of catheter-related infections may be underesti-
mated. Lastly, it may be possible that some cathe-
ter-related infections were really septicemia
managed at an outpatient facility rather than being
hospitalized. However, catheter-related infections
and septicemia had consistently similar seasonal
trends.
Conclusions
The higher rate of catheter-related septicemia in
summer may be due to higher heat and perspira-
tion, potentially facilitating bacterial growth and
compromising protective measures. Extra care and
vigilance by staff may reduce catheter-related sepsis
during this high-risk season. Prophylaxis should
include iodine-based antiseptic agents or chlorhexi-
dine cleansing of the catheter and exit site, applied
by suitably trained health care workers.
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